Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.

Singh, Awadhesh Kumar; Singh, Ritu

Singh, Awadhesh Kumar; Singh, Ritu.

Singh AK; Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India. Electronic address: drawadheshkumarsingh@gmail.com.
Singh R; Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India.

Diabetes Res Clin Pract ; 167: 108382, 2020 Sep.

Article in English | MEDLINE | ID: covidwho-728513

ABSTRACT

ABSTRACT

Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently available hints that both new-onset hyperglycemia without diabetes and new-onset diabetes in COVID-19 is associated with a poorer outcome compared with normoglycemic individuals and people with pre-existing diabetes.

Subject(s)

Coronavirus Infections/mortality; Diabetes Mellitus/epidemiology; Hyperglycemia/epidemiology; Pneumonia, Viral/mortality; Betacoronavirus; Blood Glucose/metabolism; COVID-19; Coronavirus Infections/metabolism; Diabetes Mellitus/diagnosis; Diabetes Mellitus/metabolism; Humans; Hyperglycemia/diagnosis; Hyperglycemia/metabolism; Pandemics; Pneumonia, Viral/metabolism; Prognosis; SARS-CoV-2

Keywords

COVID-19; New-onset diabetes; New-onset hyperglycemia; Outcomes; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Diabetes Mellitus / Hyperglycemia Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google